stockportfolio.pro
Stocks / KRYS vs TEM
KRYS vs TEM: Which Stock Is the Better Buy?
Krystal Biotech, Inc. and Tempus AI, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
KRYS is the larger company ($9.2B vs $8.7B). On the fundamentals, KRYS earns a higher net margin (52.6% vs -19.3%); KRYS has the stronger return on equity (16.8% vs -49.9%). On the filings, KRYS carries fewer potential red flags (2 vs 4). Full numbers below — the stronger figure on each row is in green.
AI verdict — KRYS vs TEM, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Krystal Biotech, Inc. (KRYS) | Tempus AI, Inc. (TEM) | |
|---|---|---|
| Market cap | $9.2B | $8.7B |
| Revenue (latest FY) | $389.13M | $1.27B |
| Net income (latest FY) | $204.83M | $-245.03M |
| Revenue growth (5y CAGR) | — | 58.3% |
| Net margin | 52.6% | -19.3% |
| Return on equity | 16.8% | -49.9% |
| P/E ratio | 42.0 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 3 | 0 |
| Positive free cash flow | Yes | No |
Compare with another company:
See the full KRYS vs TEM breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open KRYS's full financials → Open TEM's full financials →More comparisons
Frequently asked questions
Which is bigger, KRYS or TEM?
Krystal Biotech, Inc. is larger by market capitalization — $9.2B versus $8.7B.
Which grows faster, KRYS or TEM?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.